{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:31:42Z","timestamp":1789212702310,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kinder Foundation for their generous support and MD Anderson Moon Shot Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.critrevonc.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T04:36:53Z","timestamp":1471927013000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0772-8710","authenticated-orcid":false,"given":"Makhdum","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"Nomie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.critrevonc.2016.08.008_bib0005","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes. Dev."},{"issue":"5383","key":"10.1016\/j.critrevonc.2016.08.008_bib0010","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","article-title":"Enhanced phosphorylation of p53 by ATM in response to DNA damage","volume":"281","author":"Banin","year":"1998","journal-title":"Science"},{"issue":"45","key":"10.1016\/j.critrevonc.2016.08.008_bib0015","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0020","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/10428194.2012.711828","article-title":"Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital","volume":"54","author":"Bernard","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0025","doi-asserted-by":"publisher","first-page":"150018","DOI":"10.1098\/rsob.150018","article-title":"Ubiquitylation, neddylation and the DNA damage response","volume":"5","author":"Brown","year":"2015","journal-title":"Open Biol."},{"issue":"5383","key":"10.1016\/j.critrevonc.2016.08.008_bib0030","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.critrevonc.2016.08.008_bib0035","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1182\/blood-2015-09-672352","article-title":"Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0040","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","article-title":"Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes","volume":"26","author":"Cheah","year":"2015","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.08.008_bib0045","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.08.008_bib0050","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1074\/jbc.M611605200","article-title":"Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand Break","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4694","key":"10.1016\/j.critrevonc.2016.08.008_bib0055","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.3975628","article-title":"On the nature of a defect in cells from individuals with ataxia-telangiectasia","volume":"227","author":"Cornforth","year":"1985","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2016.08.008_bib0060","doi-asserted-by":"publisher","first-page":"iii83","DOI":"10.1093\/annonc\/mdu264","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Dreyling","year":"2014","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0065","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0955-0674(00)00201-5","article-title":"DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?","volume":"13","author":"Durocher","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.08.008_bib0070","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4161\/15384101.2014.988020","article-title":"Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia","volume":"14","author":"Ehrlich","year":"2015","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.critrevonc.2016.08.008_bib0075","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.bmt.1704238","article-title":"Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma","volume":"32","author":"Emmanouilides","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2016.08.008_bib0080","article-title":"Follicular lymphoma, immunocytoma, and mantle cell lymphoma: randomized evaluation of curative radiotherapy in limited stage nodal disease","volume":"19","author":"Engelhard","year":"2008","journal-title":"Ann. Oncol."},{"issue":"7033","key":"10.1016\/j.critrevonc.2016.08.008_bib0085","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature03442","article-title":"Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage","volume":"434","author":"Falck","year":"2005","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.critrevonc.2016.08.008_bib0090","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.0831102100","article-title":"Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma","volume":"100","author":"Fang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.critrevonc.2016.08.008_bib0095","doi-asserted-by":"publisher","first-page":"17276","DOI":"10.1074\/jbc.M011681200","article-title":"Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies","volume":"276","author":"Gatei","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0100","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","article-title":"Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis","volume":"114","author":"Gotoff","year":"1967","journal-title":"Am. J. Dis. Child."},{"issue":"7","key":"10.1016\/j.critrevonc.2016.08.008_bib0105","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1073\/pnas.0510441103","article-title":"Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma","volume":"103","author":"Greiner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.08.008_bib0110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3324\/haematol.2011.049270","article-title":"ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression","volume":"97","author":"Guarini","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.08.008_bib0115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2015.12.009","article-title":"ATM kinase: much more than a DNA damage responsive protein","volume":"39","author":"Guleria","year":"2016","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0120","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1182\/blood-2011-04-346601","article-title":"Dual mTORC1\/mTORC2 inhibition diminishes Akt activation and induces puma-dependent apoptosis in lymphoid malignancies","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.08.008_bib0125","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.clml.2014.04.013","article-title":"Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the surveillance, epidemiology and end results database","volume":"14","author":"Guru Murthy","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0130","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.clml.2014.07.003","article-title":"Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients","volume":"14","author":"Haque","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"8","key":"10.1016\/j.critrevonc.2016.08.008_bib0135","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ng.3342","article-title":"Loss-of-function variants in ATM confer risk of gastric cancer","volume":"47","author":"Helgason","year":"2015","journal-title":"Nat. Genet."},{"issue":"23","key":"10.1016\/j.critrevonc.2016.08.008_bib0140","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator\u2019s choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"27","author":"Hess","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.critrevonc.2016.08.008_bib0145","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM","volume":"64","author":"Hickson","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0150","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/leu.2015.322","article-title":"Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials","volume":"30","author":"Hoster","year":"2016","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.critrevonc.2016.08.008_bib0155","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2016.08.008_bib0160","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0165","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/02841860152619089","article-title":"ATM\u2014a key determinant of multiple cellular responses to irradiation","volume":"40","author":"Kastan","year":"2001","journal-title":"Acta Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.08.008_bib0170","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/sj.cdd.4400874","article-title":"ATM, a central controller of cellular responses to DNA damage","volume":"8","author":"Khanna","year":"2001","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.critrevonc.2016.08.008_bib0175","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/annonc\/mdg414","article-title":"Limited-stage mantle-cell lymphoma","volume":"14","author":"Leitch","year":"2003","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0180","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.stemcr.2015.10.010","article-title":"Spontaneous ATM gene reversion in A-T iPSC to produce an isogenic cell line","volume":"5","author":"Lin","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"39","key":"10.1016\/j.critrevonc.2016.08.008_bib0185","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1038\/sj.onc.1206826","article-title":"Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma","volume":"22","author":"M\u2019Kacher","year":"2003","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.critrevonc.2016.08.008_bib0190","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"12","key":"10.1016\/j.critrevonc.2016.08.008_bib0195","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/blood-2015-10-673145","article-title":"Post-ibrutinib outcomes in patients with mantle cell lymphoma","volume":"127","author":"Martin","year":"2016","journal-title":"Blood"},{"issue":"5828","key":"10.1016\/j.critrevonc.2016.08.008_bib0200","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0205","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/bjh.12046","article-title":"Guidelines for the investigation and management of mantle cell lymphoma","volume":"159","author":"McKay","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"16","key":"10.1016\/j.critrevonc.2016.08.008_bib0210","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","volume":"121","author":"Meissner","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2016.08.008_bib0215","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","article-title":"High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience","volume":"22","author":"Milpied","year":"1998","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.critrevonc.2016.08.008_bib0220","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1172\/JCI73932","article-title":"Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium","volume":"124","author":"Moding","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"278","key":"10.1016\/j.critrevonc.2016.08.008_bib0225","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4214","article-title":"Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy","volume":"7","author":"Moding","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0230","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s002470050578","article-title":"Malignancies in pediatric patients with ataxia telangiectasia","volume":"29","author":"Murphy","year":"1999","journal-title":"Pediatr. Radiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0235","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","article-title":"Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries","volume":"93","author":"Olsen","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.08.008_bib0240","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0245","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/leu.2014.223","article-title":"The EBMT\/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma","volume":"29","author":"Robinson","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0250","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijrobp.2006.02.011","article-title":"Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT)","volume":"65","author":"Rosenbluth","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"23","key":"10.1016\/j.critrevonc.2016.08.008_bib0255","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.336.336","article-title":"A molecular model for the prediction of progression free survival in young mantle cell lymphoma patients treated with cytarabine-based high dose sequential chemotherapy and autologous stem cell transplantation: results from the MCL0208 phase III trial fr\u2026","volume":"126","author":"Rossi","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0260","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.08.008_bib0265","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0959-437X(00)00159-3","article-title":"ATM and ATR: networking cellular responses to DNA damage","volume":"11","author":"Shiloh","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.08.008_bib0270","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.08.008_bib0275","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3324\/haematol.2011.048827","article-title":"ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele","volume":"97","author":"Skowronska","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0280","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10147-014-0717-z","article-title":"Radiobiological basis of SBRT and SRS","volume":"19","author":"Song","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.08.008_bib0285","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.critrevonc.2016.08.008_bib0290","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1182\/blood-2002-04-1078","article-title":"CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas","volume":"100","author":"Tort","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.08.008_bib0295","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cge.12710","article-title":"Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline","volume":"90","author":"van Os","year":"2016","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.08.008_bib0300","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.08.008_bib0305","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1074\/jbc.M211168200","article-title":"Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains","volume":"278","author":"Weizman","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2016.08.008_bib0310","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/1078-0432.CCR-07-5158","article-title":"DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-Cell chronic lymphocytic leukemia","volume":"14","author":"Willmore","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.08.008_bib0315","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11864-006-0038-1","article-title":"Inhibition of the phosphatidylinositol 3-kinase\/mammalian target of rapamycin pathway in hematologic malignancies","volume":"7","author":"Witzig","year":"2016","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.08.008_bib0320","doi-asserted-by":"publisher","first-page":"288","DOI":"10.6004\/jnccn.2010.0021","article-title":"NCCN clinical practice guidelines in oncology: non-Hodgkin\u2019s lymphomas","volume":"8","author":"Zelenetz","year":"2010","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"19","key":"10.1016\/j.critrevonc.2016.08.008_bib0325","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816301858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816301858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T08:31:47Z","timestamp":1601022707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816301858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":65,"alternative-id":["S1040842816301858"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.08.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727002465.793548371","asserted-by":"object"}]},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}